The Role of Immunity and Inflammation in Lung Senescence and Susceptibility to Infection in the Elderly

ABSTRACT

Advancing age is associated with a decline in the integrity of physical barriers and protection against invading pathogens, and age-related changes in the immune system are associated with increased susceptibility to the emergence of autoimmune phenomena, neoplasia, and infections. Respiratory tract infections can occur at any age, but the incidence of lower respiratory tract infections increases significantly with advanced age such that pneumonia is a leading cause of illness and death in the elderly. Changes in lung physiology and immune function coupled with inflammation induced by environmental exposures or endogenous factors such as predisposition to aspiration may, in part, account for the increase in susceptibility to respiratory infections. Additionally, age-associated alterations in immune regulation (“immunosenescence”) with dysregulation of lung homeostasis may allow low-grade inflammatory changes that lead to anatomical and physiological changes that characterize the senescent lung. The presence of disease states in elderly populations, such as chronic obstructive pulmonary disease (COPD) or nonpulmonary organ system diseases, may increase the likelihood of developing severe respiratory infections. This article examines age-related changes in immune function that predispose elderly individuals to lung remodeling but focuses especially on lower respiratory tract infections. It will discuss risk factors, identify pathogens that typically lead to respiratory infections in the elderly, and review current approaches to treatment and prevention of respiratory infections in the elderly population.

KEYWORDS

Lung - aging - aged - elderly - pneumonia - immunosenescence - immunity

REFERENCES

• 1 Pawelec G, Larbi A. Immunity and ageing in man: Annual Review 2006/2007.  Exp Gerontol. 2008;  43 34-38
• 2 Hasler P, Zouali M. Immune receptor signaling, aging, and autoimmunity.  Cell Immunol. 2005;  233 102-108
• 3 Meyer K C. Aging.  Proc Am Thorac Soc. 2005;  2 433-439
• 4 Franceschi C, Bonafè M, Valensin S. Human immunosenescence: the prevailing of innate immunity, the failing of clonotypic immunity, and the filling of immunological space.  Vaccine. 2000;  18 1717-1720
• 5 Franceschi C, Bonafè M. Centenarians as a model for healthy aging.  Biochem Soc Trans. 2003;  31 457-461
• 6 Franceschi C, Monti D, Sansoni P, Cossarizza A. The immunology of exceptional individuals: the lesson of centenarians.  Immunol Today. 1995;  16 12-16
• 7 Meyer K C. The aging human lung: age-associated changes in structure and function. In: Conn PM Handbook of Models for Human Aging. Boston, MA; Elsevier Academic 2006: 727-734
• 8 Thompson A B, Scholer S G, Daughton D M, Potter J F, Rennard S I. Altered epithelial lining fluid parameters in old normal individuals.  J Gerontol. 1992;  47 M171-M176
• 9 Meyer K C, Ershler W, Rosenthal N S, Lu X G, Peterson K. Immune dysregulation in the aging human lung.  Am J Respir Crit Care Med. 1996;  153 1072-1079
• 10 Meyer K C, Rosenthal N S, Soergel P, Peterson K. Neutrophils and low-grade inflammation in the seemingly normal aging human lung.  Mech Ageing Dev. 1998;  104 169-181
• 11 Meyer K C, Soergel P. Variation of bronchoalveolar lymphocyte phenotypes with age in the physiologically normal human lung.  Thorax. 1999;  54 697-700
• 12 Meyer K C, Cardoni A, Xiang Z Z. Vascular endothelial growth factor in bronchoalveolar lavage from normal subjects and patients with diffuse parenchymal lung disease.  J Lab Clin Med. 2000;  135 332-338
• 13 Harms K L, Chen X. Histone deacetylase 2 modulates p53 transcriptional activities through regulation of p53-DNA binding activity.  Cancer Res. 2007;  67 3145-3152
• 14 Delves P J, Roitt I M. The immune system: first of two parts.  N Engl J Med. 2000;  343 37-49
• 15 Delves P J, Roitt I M. The immune system: second of two parts.  N Engl J Med. 2000;  343 108-117
• 16 Medzhitov R, Janeway Jr C J. Innate immunity.  N Engl J Med. 2000;  343 338-344
• 17 Monie T P, Bryant C E, Gay N J. Activating immunity: lessons from the TLRs and NLRs.  Trends Biochem Sci. 2009;  34 553-561
• 18 Medzhitov R, Janeway Jr C. Innate immune recognition: mechanisms and pathways.  Immunol Rev. 2000;  173 89-97
• 19 Zhang P, Summer W R, Bagby G J, Nelson S. Innate immunity and pulmonary host defense.  Immunol Rev. 2000;  173 39-51
• 20 Corberand J, Ngyen F, Laharrague P et al.. Polymorphonuclear functions and aging in humans.  J Am Geriatr Soc. 1981;  29 391-397
• 21 Fu Y K, Arkins S, Li Y M, Dantzer R, Kelley K W. Reduction in superoxide anion secretion and bactericidal activity of neutrophils from aged rats: reversal by the combination of gamma interferon and growth hormone.  Infect Immun. 1994;  62 1-8
• 22 Tortorella C, Ottolenghi A, Pugliese P, Jirillo E, Antonaci S. Relationship between respiratory burst and adhesiveness capacity in elderly polymorphonuclear cells.  Mech Ageing Dev. 1993;  69 53-63
• 23 Fülöp Jr T, Fouquet C, Allaire P et al.. Changes in apoptosis of human polymorphonuclear granulocytes with aging.  Mech Ageing Dev. 1997;  96 15-34
• 24 Tortorella C, Piazzolla G, Spaccavento F, Pece S, Jirillo E, Antonaci S. Spontaneous and Fas-induced apoptotic cell death in aged neutrophils.  J Clin Immunol. 1998;  18 321-329
• 25 Szakal A K, Kapasi Z F, Masuda A, Tew J G. Follicular dendritic cells in the alternative antigen transport pathway: microenvironment, cellular events, age and retrovirus related alterations.  Semin Immunol. 1992;  4 257-265
• 26 Pietschmann P, Hahn P, Kudlacek S, Thomas R, Peterlik M. Surface markers and transendothelial migration of dendritic cells from elderly subjects.  Exp Gerontol. 2000;  35 213-224
• 27 Steger M M, Maczek C, Grubeck-Loebenstein B. Morphologically and functionally intact dendritic cells can be derived from the peripheral blood of aged individuals.  Clin Exp Immunol. 1996;  105 544-550
• 28 Lung T L, Saurwein-Teissl M, Parson W, Schönitzer D, Grubeck-Loebenstein B. Unimpaired dendritic cells can be derived from monocytes in old age and can mobilize residual function in senescent T cells.  Vaccine. 2000;  18 1606-1612
• 29 Shodell M, Siegal F P. Circulating, interferon-producing plasmacytoid dendritic cells decline during human ageing.  Scand J Immunol. 2002;  56 518-521
• 30 Davila D R, Edwards III C K, Arkins S, Simon J, Kelley K W. Interferon-gamma-induced priming for secretion of superoxide anion and tumor necrosis factor-alpha declines in macrophages from aged rats.  FASEB J. 1990;  4 2906-2911
• 31 Alvarez E, Machado A, Sobrino F, Santa Maria C. Nitric oxide and superoxide anion production decrease with age in resident and activated rat peritoneal macrophages.  Cell Immunol. 1996;  169 152-155
• 32 Lavie L, Weinreb O, Gershon D. Age-related alterations in superoxide anion generation in mouse peritoneal macrophages studied by repeated stimulations and heat shock treatment.  J Cell Physiol. 1992;  152 382-388
• 33 Khare P D, Dhawan R, Chaturvedi U C. Identification and characterization of receptor for dengue virus-induced macrophage cytotoxin.  Indian J Exp Biol. 1996;  34 652-657
• 34 Chen L C, Pace J L, Russell S W, Morrison D C. Altered regulation of inducible nitric oxide synthase expression in macrophages from senescent mice.  Infect Immun. 1996;  64 4288-4298
• 35 Renshaw M, Rockwell J, Engleman C, Gewirtz A, Katz J, Sambhara S. Cutting edge: impaired Toll-like receptor expression and function in aging.  J Immunol. 2002;  169 4697-4701
• 36 Boehmer E D, Goral J, Faunce D E, Kovacs E J. Age-dependent decrease in Toll-like receptor 4-mediated proinflammatory cytokine production and mitogen-activated protein kinase expression.  J Leukoc Biol. 2004;  75 342-349
• 37 Swift M E, Burns A L, Gray K L, DiPietro L A. Age-related alterations in the inflammatory response to dermal injury.  J Invest Dermatol. 2001;  117 1027-1035
• 38 Ashcroft G S, Horan M A, Ferguson M W. Aging alters the inflammatory and endothelial cell adhesion molecule profiles during human cutaneous wound healing.  Lab Invest. 1998;  78 47-58
• 39 McNerlan S E, Rea I M, Alexander H D, Morris T C. Changes in natural killer cells, the CD57CD8 subset, and related cytokines in healthy aging.  J Clin Immunol. 1998;  18 31-38
• 40 Ogata K, Yokose N, Tamura H et al.. Natural killer cells in the late decades of human life.  Clin Immunol Immunopathol. 1997;  84 269-275
• 41 Miyaji C, Watanabe H, Toma H et al.. Functional alteration of granulocytes, NK cells, and natural killer T cells in centenarians.  Hum Immunol. 2000;  61 908-916
• 42 Poynter M E, Mu H H, Chen X P, Daynes R A. Activation of NK1.1 + T cells in vitro and their possible role in age-associated changes in inducible IL-4 production.  Cell Immunol. 1997;  179 22-29
• 43 Dubey D P, Husain Z, Levitan E et al.. The MHC influences NK and NKT cell functions associated with immune abnormalities and lifespan.  Mech Ageing Dev. 2000;  113 117-134
• 44 Flurkey K, Stadecker M, Miller R A. Memory T lymphocyte hyporesponsiveness to non-cognate stimuli: a key factor in age-related immunodeficiency.  Eur J Immunol. 1992;  22 931-935
• 45 Naylor K, Li G, Vallejo A N et al.. The influence of age on T cell generation and TCR diversity.  J Immunol. 2005;  174 7446-7452
• 46 Swain S, Clise-Dwyer K, Haynes L. Homeostasis and the age-associated defect of CD4 T cells.  Semin Immunol. 2005;  17 370-377
• 47 Cakman I, Rohwer J, Schütz R M, Kirchner H, Rink L. Dysregulation between TH1 and TH2 T cell subpopulations in the elderly.  Mech Ageing Dev. 1996;  87 197-209
• 48 Zhou T, Edwards III C K, Mountz J D. Prevention of age-related T cell apoptosis defect in CD2-fas-transgenic mice.  J Exp Med. 1995;  182 129-137
• 49 Jackola D R, Ruger J K, Miller R A. Age-associated changes in human T cell phenotype and function.  Aging (Milano). 1994;  6 25-34
• 50 McKenna R W, Washington L T, Aquino D B, Picker L J, Kroft S H. Immunophenotypic analysis of hematogones (B-lymphocyte precursors) in 662 consecutive bone marrow specimens by 4-color flow cytometry.  Blood. 2001;  98 2498-2507
• 51 Dailey R W, Eun S Y, Russell C E, Vogel L A. B cells of aged mice show decreased expansion in response to antigen, but are normal in effector function.  Cell Immunol. 2001;  214 99-109
• 52 Doria G, D'Agostaro G, Poretti A. Age-dependent variations of antibody avidity.  Immunology. 1978;  35 601-611
• 53 Yang X, Stedra J, Cerny J. Relative contribution of T and B cells to hypermutation and selection of the antibody repertoire in germinal centers of aged mice.  J Exp Med. 1996;  183 959-970
• 54 Ferguson F G, Wikby A, Maxson P, Olsson J, Johansson B. Immune parameters in a longitudinal study of a very old population of Swedish people: a comparison between survivors and nonsurvivors.  J Gerontol A Biol Sci Med Sci. 1995;  50 B378-B382
• 55 Butcher S K, Lord J M. Stress responses and innate immunity: aging as a contributory factor.  Aging Cell. 2004;  3 151-160
• 56 Verbeken E K, Cauberghs M, Mertens I, Clement J, Lauweryns J M, Van de Woestijne K P. The senile lung: comparison with normal and emphysematous lungs. 1. Structural aspects.  Chest. 1992;  101 793-799
• 57 Fishman A P. One hundred years of chronic obstructive pulmonary disease.  Am J Respir Crit Care Med. 2005;  171 941-948
• 58 Mittman C, Edelman N H, Norris A H, Shock N W. Relationship between chest wall and pulmonary compliance and age.  J Appl Physiol. 1965;  20 1211-1216
• 59 Turner J M, Mead J, Wohl M E. Elasticity of human lungs in relation to age.  J Appl Physiol. 1968;  25 664-671
• 60 Hancock D B, Eijgelsheim M, Wilk J B et al.. Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function.  Nat Genet. 2010;  42 45-52
• 61 Edge J R, Millard F J, Reid L, Simon G. The radiographic appearances of the chest in persons of advanced age.  Br J Radiol. 1964;  37 769-774
• 62 Tolep K, Kelsen S G. Effect of aging on respiratory skeletal muscles.  Clin Chest Med. 1993;  14 363-378
• 63 Polkey M I, Harris M L, Hughes P D et al.. The contractile properties of the elderly human diaphragm.  Am J Respir Crit Care Med. 1997;  155 1560-1564
• 64 Evans S A, Watson L, Hawkins M, Cowley A J, Johnston I D, Kinnear W J. Respiratory muscle strength in chronic heart failure.  Thorax. 1995;  50 625-628
• 65 Mancini D M, Henson D, LaManca J, Levine S. Respiratory muscle function and dyspnea in patients with chronic congestive heart failure.  Circulation. 1992;  86 909-918
• 66 Verdery R B. Malnutrition and chronic inflammation: causes or effects of frailty.  Aging Clin Exp Res. 1992;  4 262-263
• 67 Shaker R, Ren J L, Bardan E et al.. Pharyngoglottal closure reflex: characterization in healthy young, elderly and dysphagic patients with predeglutitive aspiration.  Gerontology. 2003;  49 12-20
• 68 Nakayama K, Jia Y X, Hirai H et al.. Acid stimulation reduces bactericidal activity of surface liquid in cultured human airway epithelial cells.  Am J Respir Cell Mol Biol. 2002;  26 105-113
• 69 Chouinard J. Dysphagia in Alzheimer disease: a review.  J Nutr Health Aging. 2000;  4 214-217
• 70 Ruiz M, Ewig S, Marcos M A et al.. Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity.  Am J Respir Crit Care Med. 1999;  160 397-405
• 71 Puchelle E, Zahm J M, Bertrand A. Influence of age on bronchial mucociliary transport.  Scand J Respir Dis. 1979;  60 307-313
• 72 Ho J C, Chan K N, Hu W H et al.. The effect of aging on nasal mucociliary clearance, beat frequency, and ultrastructure of respiratory cilia.  Am J Respir Crit Care Med. 2001;  163 983-988
• 73 Plowden J, Renshaw-Hoelscher M, Engleman C, Katz J, Sambhara S. Innate immunity in aging: impact on macrophage function.  Aging Cell. 2004;  3 161-167
• 74 Koike E, Kobayashi T, Mochitate K, Murakami M. Effect of aging on nitric oxide production by rat alveolar macrophages.  Exp Gerontol. 1999;  34 889-894
• 75 Corsini E, Battaini F, Lucchi L et al.. A defective protein kinase C anchoring system underlying age-associated impairment in TNF-alpha production in rat macrophages.  J Immunol. 1999;  163 3468-3473
• 76 Zissel G, Schlaak M, Müller-Quernheim J. Age-related decrease in accessory cell function of human alveolar macrophages.  J Investig Med. 1999;  47 51-56
• 77 Corsini E, Di Paola R, Viviani B et al.. Increased carrageenan-induced acute lung inflammation in old rats.  Immunology. 2005;  115 253-261
• 78 Ito K, Barnes P J. COPD as a disease of accelerated lung aging.  Chest. 2009;  135 173-180
• 79 Fletcher C, Peto R. The natural history of chronic airflow obstruction.  BMJ. 1977;  1 1645-1648
• 80 Harman D. Free radical theory of aging: an update: increasing the functional life span.  Ann N Y Acad Sci. 2006;  1067 10-21
• 81 Promislow D E. DNA repair and the evolution of longevity: a critical analysis.  J Theor Biol. 1994;  170 291-300
• 82 Gupte A A, Bomhoff G L, Geiger P C. Age-related differences in skeletal muscle insulin signaling: the role of stress kinases and heat shock proteins.  J Appl Physiol. 2008;  105 839-848
• 83 Rahman I, Adcock I M. Oxidative stress and redox regulation of lung inflammation in COPD.  Eur Respir J. 2006;  28 219-242
• 84 Ito K. Does lung aging have an impact on chronic obstructive pulmonary disease?.  J Organ Dysfunction. 2007;  3 204-220
• 85 Grubisha O, Smith B C, Denu J M. Small molecule regulation of Sir2 protein deacetylases.  FEBS J. 2005;  272 4607-4616
• 86 Suga T, Kurabayashi M, Sando Y et al.. Disruption of the klotho gene causes pulmonary emphysema in mice: defect in maintenance of pulmonary integrity during postnatal life.  Am J Respir Cell Mol Biol. 2000;  22 26-33
• 87 Maruyama N, Ishigami A, Kuramoto M et al.. Senescence marker protein-30 knockout mouse as an aging model.  Ann N Y Acad Sci. 2004;  1019 383-387
• 88 Vogel H, Lim D S, Karsenty G, Finegold M, Hasty P. Deletion of Ku86 causes early onset of senescence in mice.  Proc Natl Acad Sci U S A. 1999;  96 10770-10775
• 89 Sato T, Seyama K, Sato Y et al.. Senescence marker protein-30 protects mice lungs from oxidative stress, aging, and smoking.  Am J Respir Crit Care Med. 2006;  174 530-537
• 90 Collins K, Mitchell J R. Telomerase in the human organism.  Oncogene. 2002;  21 564-579
• 91 Jiang H, Ju Z, Rudolph K L. Telomere shortening and ageing.  Z Gerontol Geriatr. 2007;  40 314-324
• 92 von Zglinicki T. Oxidative stress shortens telomeres.  Trends Biochem Sci. 2002;  27 339-344
• 93 Tsuji T, Aoshiba K, Nagai A. Alveolar cell senescence in patients with pulmonary emphysema.  Am J Respir Crit Care Med. 2006;  174 886-893
• 94 Morlá M, Busquets X, Pons J, Sauleda J, MacNee W, Agustí A G. Telomere shortening in smokers with and without COPD.  Eur Respir J. 2006;  27 525-528
• 95 Garcia C K, Wright W E, Shay J W. Human diseases of telomerase dysfunction: insights into tissue aging.  Nucleic Acids Res. 2007;  35 7406-7416
• 96 Alder J K, Chen J J, Lancaster L et al.. Short telomeres are a risk factor for idiopathic pulmonary fibrosis.  Proc Natl Acad Sci U S A. 2008;  105 13051-13056
• 97 Tsakiri K D, Cronkhite J T, Kuan P J et al.. Adult-onset pulmonary fibrosis caused by mutations in telomerase.  Proc Natl Acad Sci U S A. 2007;  104 7552-7557
• 98 Hogg J C, van Eeden S. Pulmonary and systemic response to atmospheric pollution.  Respirology. 2009;  14 336-346
• 99 Oberdörster G. Pulmonary effects of inhaled ultrafine particles.  Int Arch Occup Environ Health. 2001;  74 1-8
• 100 Neupane B, Jerrett M, Burnett R T, Marrie T, Arain A, Loeb M. Long-term exposure to ambient air pollution and risk of hospitalization with community-acquired pneumonia in older adults.  Am J Respir Crit Care Med. 2010;  181 47-53
• 101 Zanobetti A, Bind M A, Schwartz J. Particulate air pollution and survival in a COPD cohort.  Environ Health. 2008;  7 48
• 102 Mora A L, Rojas M. Aging and lung injury repair: a role for bone marrow derived mesenchymal stem cells.  J Cell Biochem. 2008;  105 641-647
• 103 Ruzankina Y, Asare A, Brown E J. Replicative stress, stem cells and aging.  Mech Ageing Dev. 2008;  129 460-466
• 104 Butcher S K, Lord J M. Stress responses and innate immunity: aging as a contributory factor.  Aging Cell. 2004;  3 151-160
• 105 Goncharova N D, Lapin B A. Age-related endocrine dysfunction in nonhuman primates.  Ann N Y Acad Sci. 2004;  1019 321-325
• 106 Grimble R F. Inflammatory response in the elderly.  Curr Opin Clin Nutr Metab Care. 2003;  6 21-29
• 107 Barnes P J. Corticosteroid resistance in airway disease.  Proc Am Thorac Soc. 2004;  1 264-268
• 108 Lages C S, Suffia I, Velilla P A et al.. Functional regulatory T cells accumulate in aged hosts and promote chronic infectious disease reactivation.  J Immunol. 2008;  181 1835-1848
• 109 Weyand C M, Brandes J C, Schmidt D, Fulbright J W, Goronzy J J. Functional properties of CD4 + CD28−T cells in the aging immune system.  Mech Ageing Dev. 1998;  102 131-147
• 110 Bryl E, Vallejo A N, Weyand C M, Goronzy J J. Down-regulation of CD28 expression by TNF-alpha.  J Immunol. 2001;  167 3231-3238
• 111 Gilani S R, Vuga L J, Lindell K O et al.. CD28 down-regulation on circulating CD4 T-cells is associated with poor prognoses of patients with idiopathic pulmonary fibrosis.  PLoS One. 2010;  5 e8959
• 112 Zalacain R, Torres A. Pneumonia in the elderly.  Clin Pulm Med. 2004;  11 210-218
• 113 Treanor J, Falsey A. Respiratory viral infections in the elderly.  Antiviral Res. 1999;  44 79-102
• 114 Metlay J P, Schulz R, Li Y H et al.. Influence of age on symptoms at presentation in patients with community-acquired pneumonia.  Arch Intern Med. 1997;  157 1453-1459
• 115 Niederman M S, Mandell L A, Anzueto A American Thoracic Society et al. Guidelines for the management of adults with community-acquired pneumonia: diagnosis, assessment of severity, antimicrobial therapy, and prevention.  Am J Respir Crit Care Med. 2001;  163 1730-1754
• 116 Fine M J, Auble T E, Yealy D M et al.. A prediction rule to identify low-risk patients with community-acquired pneumonia.  N Engl J Med. 1997;  336 243-250
• 117 Meehan T P, Fine M J, Krumholz H M et al.. Quality of care, process, and outcomes in elderly patients with pneumonia.  JAMA. 1997;  278 2080-2084
• 118 Falsey A R, Walsh E E. Viral pneumonia in older adults.  Clin Infect Dis. 2006;  42 518-524
• 119 Thompson W W, Shay D K, Weintraub E et al.. Influenza-associated hospitalizations in the United States.  JAMA. 2004;  292 1333-1340
• 120 Bradley S F. Long-Term-Care Committee of the Society for Healthcare Epidemiology of America . Prevention of influenza in long-term-care facilities.  Infect Control Hosp Epidemiol. 1999;  20 629-637
• 121 Falsey A R, Hennessey P A, Formica M A, Cox C, Walsh E E. Respiratory syncytial virus infection in elderly and high-risk adults.  N Engl J Med. 2005;  352 1749-1759
• 122 Looney R J, Falsey A R, Walsh E, Campbell D. Effect of aging on cytokine production in response to respiratory syncytial virus infection.  J Infect Dis. 2002;  185 682-685
• 123 Hicks L A, Shepard C W, Britz P H et al.. Two outbreaks of severe respiratory disease in nursing homes associated with rhinovirus.  J Am Geriatr Soc. 2006;  54 284-289
• 124 Louie J K, Yagi S, Nelson F A et al.. Rhinovirus outbreak in a long term care facility for elderly persons associated with unusually high mortality.  Clin Infect Dis. 2005;  41 262-265
• 125 Mosser A G, Vrtis R, Burchell L et al.. Quantitative and qualitative analysis of rhinovirus infection in bronchial tissues.  Am J Respir Crit Care Med. 2005;  171 645-651
• 126 Laforce F M, Hopkins J, Trow R, Wang W L. Human oral defenses against gram-negative rods.  Am Rev Respir Dis. 1976;  114 929-935
• 127 Smaldone G C. Deposition and clearance: unique problems in the proximal airways and oral cavity in the young and elderly.  Respir Physiol. 2001;  128 33-38
• 128 Palmer L B, Albulak K, Fields S, Filkin A M, Simon S, Smaldone G C. Oral clearance and pathogenic oropharyngeal colonization in the elderly.  Am J Respir Crit Care Med. 2001;  164 464-468
• 129 Ayars G H, Altman L C, Fretwell M D. Effect of decreased salivation and pH on the adherence of Klebsiella species to human buccal epithelial cells.  Infect Immun. 1982;  38 179-182
• 130 Kikuchi R, Watabe N, Konno T, Mishina N, Sekizawa K, Sasaki H. High incidence of silent aspiration in elderly patients with community-acquired pneumonia.  Am J Respir Crit Care Med. 1994;  150 251-253
• 131 Matsuse T, Oka T, Kida K, Fukuchi Y. Importance of diffuse aspiration bronchiolitis caused by chronic occult aspiration in the elderly.  Chest. 1996;  110 1289-1293
• 132 Nakayama K, Jia Y X, Hirai H et al.. Acid stimulation reduces bactericidal activity of surface liquid in cultured human airway epithelial cells.  Am J Respir Cell Mol Biol. 2002;  26 105-113
• 133 Riquelme R, Torres A, El-Ebiary M et al.. Community-acquired pneumonia in the elderly: a multivariate analysis of risk and prognostic factors.  Am J Respir Crit Care Med. 1996;  154 1450-1455
• 134 Lesourd B M. Nutrition: a major factor influencing immunity in the elderly.  J Nutr Health Aging. 2004;  8 28-37
• 135 Yeh S S, Schuster M W. Geriatric cachexia: the role of cytokines.  Am J Clin Nutr. 1999;  70 183-197
• 136 Pamuk E R, Williamson D F, Serdula M K, Madans J, Byers T E. Weight loss and subsequent death in a cohort of U.S. adults.  Ann Intern Med. 1993;  119(7 Pt 2) 744-748
• 137 Maffei M, Halaas J, Ravussin E et al.. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects.  Nat Med. 1995;  1 1155-1161
• 138 Mancuso P, Gottschalk A, Phare S M, Peters-Golden M, Lukacs N W, Huffnagle G B. Leptin-deficient mice exhibit impaired host defense in gram-negative pneumonia.  J Immunol. 2002;  168 4018-4024
• 139 Ernst P, Gonzalez A V, Brassard P, Suissa S. Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of hospitalization for pneumonia.  Am J Respir Crit Care Med. 2007;  176 162-166
• 140 Calverley P M, Anderson J A, Celli B TORCH investigators et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease.  N Engl J Med. 2007;  356 775-789
• 141 Sin D D, Tashkin D, Zhang X et al.. Budesonide and the risk of pneumonia: a meta-analysis of individual patient data.  Lancet. 2009;  374 712-719
• 142 Welte T. Inhaled corticosteroids in COPD and the risk of pneumonia.  Lancet. 2009;  374 668-670
• 143 Eurich D T, Sadowski C A, Simpson S H, Marrie T J, Majumdar S R. Recurrent community-acquired pneumonia in patients starting acid-suppressing drugs.  Am J Med. 2010;  123 47-53
• 144 Laheij R J, Sturkenboom M C, Hassing R J, Dieleman J, Stricker B H, Jansen J B. Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs.  JAMA. 2004;  292 1955-1960
• 145 Sarkar M, Hennessy S, Yang Y X. Proton-pump inhibitor use and the risk for community-acquired pneumonia.  Ann Intern Med. 2008;  149 391-398
• 146 Bartlett J G, Mundy L M. Community-acquired pneumonia.  N Engl J Med. 1995;  333 1618-1624
• 147 Rossman J S, Lamb R A. Swine-origin influenza virus and the 2009 pandemic.  Am J Respir Crit Care Med. 2010;  181 295-296
• 148 Reed C, Angulo F J, Swerdlow D L et al.. Estimates of the prevalence of pandemic (H1N1) 2009, United States, April–July 2009.  Emerg Infect Dis. 2009;  15 2004-2007
• 149 Louie J K, Acosta M, Winter K California Pandemic (H1N1) Working Group et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California.  JAMA. 2009;  302 1896-1902
• 150 Ciancio B C, Meerhoff T J, Kramarz P et al.. Oseltamivir-resistant influenza A(H1N1) viruses detected in Europe during season 2007–8 had epidemiologic and clinical characteristics similar to co-circulating susceptible A(H1N1) viruses.  Euro Surveill. 2009;  14(46). pii 19412
• 151 Fagiolo U, Amadori A, Cozzi E et al.. Humoral and cellular immune response to influenza virus vaccination in aged humans.  Aging (Milano). 1993;  5 451-458
• 152 Artz A S, Ershler W B, Longo D L. Pneumococcal vaccination and revaccination of older adults.  Clin Microbiol Rev. 2003;  16 308-318
• 153 Gross P A, Hermogenes A W, Sacks H S, Lau J, Levandowski R A. The efficacy of influenza vaccine in elderly persons: a meta-analysis and review of the literature.  Ann Intern Med. 1995;  123 518-527
• 154 Sisk J E, Moskowitz A J, Whang W et al.. Cost-effectiveness of vaccination against pneumococcal bacteremia among elderly people.  JAMA. 1997;  278 1333-1339
• 155 Butler J C, Breiman R F, Campbell J F, Lipman H B, Broome C V, Facklam R R. Pneumococcal polysaccharide vaccine efficacy: an evaluation of current recommendations.  JAMA. 1993;  270 1826-1831
• 156 Simberkoff M S, Cross A P, Al-Ibrahim M et al.. Efficacy of pneumococcal vaccine in high-risk patients: results of a Veterans Administration Cooperative Study.  N Engl J Med. 1986;  315 1318-1327
• 157 Ortqvist A. Pneumococcal vaccination: current and future issues.  Eur Respir J. 2001;  18 184-195
• 158 Dear K, Holden J, Andrews R, Tatham D. Vaccines for preventing pneumococcal infection in adults.  Cochrane Database Syst Rev. 2003;  (4) CD000422
• 159 Evans S E, Scott B L, Clement C G et al.. Stimulated innate resistance of lung epithelium protects mice broadly against bacteria and fungi.  Am J Respir Cell Mol Biol. 2010;  42 40-50
• 160 Nichol K L, Margolis K L, Wuorenma J, Von Sternberg T. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community.  N Engl J Med. 1994;  331 778-784
• 161 Ghendon Y Z, Kaira A N, Elshina G A. The effect of mass influenza immunization in children on the morbidity of the unvaccinated elderly.  Epidemiol Infect. 2006;  134 71-78
• 162 Reichert T A, Sugaya N, Fedson D S, Glezen W P, Simonsen L, Tashiro M. The Japanese experience with vaccinating schoolchildren against influenza.  N Engl J Med. 2001;  344 889-896
• 163 Centers for Disease Control and Prevention (CDC) . Interim results: influenza A (H1N1) 2009 monovalent vaccination coverage: United States, October–December 2009.  MMWR Morb Mortal Wkly Rep. 2010;  59 44-48